- Home
- NIXX vs ACET Comparison
NIXX vs ACET Comparison
Compare NIXX & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIXX
- ACET
- Stock Information
- Founded
- NIXX 2010
- ACET 1947
- Country
- NIXX United States
- ACET United States
- Employees
- NIXX N/A
- ACET N/A
- Industry
- NIXX
- ACET Biotechnology: Pharmaceutical Preparations
- Sector
- NIXX
- ACET Health Care
- Exchange
- NIXX NYSE
- ACET Nasdaq
- Market Cap
- NIXX 66.8M
- ACET 75.6M
- IPO Year
- NIXX N/A
- ACET N/A
- Fundamental
- Price
- NIXX $4.44
- ACET $0.91
- Analyst Decision
- NIXX
- ACET Strong Buy
- Analyst Count
- NIXX 0
- ACET 4
- Target Price
- NIXX N/A
- ACET $5.67
- AVG Volume (30 Days)
- NIXX 276.1K
- ACET 513.3K
- Earning Date
- NIXX 11-14-2024
- ACET 11-06-2024
- Dividend Yield
- NIXX N/A
- ACET N/A
- EPS Growth
- NIXX N/A
- ACET N/A
- EPS
- NIXX N/A
- ACET N/A
- Revenue
- NIXX $668,693.00
- ACET N/A
- Revenue This Year
- NIXX $209.13
- ACET N/A
- Revenue Next Year
- NIXX N/A
- ACET N/A
- P/E Ratio
- NIXX N/A
- ACET N/A
- Revenue Growth
- NIXX N/A
- ACET N/A
- 52 Week Low
- NIXX $1.12
- ACET $0.81
- 52 Week High
- NIXX $8.50
- ACET $3.62
- Technical
- Relative Strength Index (RSI)
- NIXX N/A
- ACET 43.86
- Support Level
- NIXX N/A
- ACET $0.85
- Resistance Level
- NIXX N/A
- ACET $0.94
- Average True Range (ATR)
- NIXX 0.00
- ACET 0.08
- MACD
- NIXX 0.00
- ACET 0.00
- Stochastic Oscillator
- NIXX 0.00
- ACET 22.16
About NIXX NIXXY INC
Nixxy Inc formerly Recruiter.Com Group Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize a web platform, complete with AI-driven job matching, to recruit talent faster. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.